Confluent Retikulearre Papillomatose (Confluent reticulated papillomatosis) is in ûngewoane, mar ûnderskiedende ferwurve ichthyosiforme dermatosis, karakterisearre troch oanhâldende tsjustere, skaalige flekken dy't de neiging hawwe om benammen op de sintrale romp te ferskine. De sykte kin behannele wurde mei Minocycline.
Confluent and reticulated papillomatosis of Gougerot and Carteaud is an uncommon but distinctive acquired ichthyosiform dermatosis characterized by persistent dark, scaly, papules and plaques that tend to be localized predominantly on the central trunk.
☆ AI Dermatology — Free Service Yn 'e 2022 Stiftung Warentest-resultaten út Dútslân wie de konsuminttefredenheid mei ModelDerm mar wat leger dan mei betelle telemedisynkonsultaasjes.
Typysk gefal – it ferskynt as in swarte pigmentearre plak sûnder symptomen (jeuk, pine) om de taille.
Confluent and reticulated papillomatosis (CRP), ek wol Gougerot‑Carteaud‑syndroom neamd, is it resultaat fan abnormale groei fan hûdsellen. It ferskynt as donker flekken dy't kinne gearfoegje yn gruttere plakken, meastentiids op de boppeboarst en nek fan tieners en jonge folwoeksenen. De earste kar foar behanneling is minocycline. Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.
CRP ferskynt normaal as donkere flekken en patches sûnder symptomen op 'e hûd om de nek, oksels, boppeste boarst en boppeste rêch. Soms kin it ferspriede oant de foarholle en del nei it pubeske gebiet. Antibiotika lykas minocycline binne in foarkarsbehannelingskeuze. CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.
○ Behanneling
Minocycline